CA
UTHR icon

Commerzbank Aktiengesellschaft’s United Therapeutics UTHR Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-40,129
Closed -$3.2M – 809
2019
Q3 		$3.2M Sell
40,129
-226
-0.6% -$18.2K 0.02% 356
2019
Q2 		$3.15M Buy
40,355
+570
+1% +$53.3K 0.02% 373
2019
Q1 		$4.67M Hold
39,785
– – 0.04% 275
2018
Q4 		$4.33M Hold
39,785
– – 0.04% 289
2018
Q3 		$5.09M Hold
39,785
– – 0.04% 279
2018
Q2 		$4.5M Hold
39,785
– – 0.04% 292
2018
Q1 		$4.47M Hold
39,785
– – 0.05% 278
2017
Q4 		$5.89M Hold
39,785
– – 0.07% 236
2017
Q3 		$4.66M Hold
39,785
– – 0.06% 248
2017
Q2 		$5.16M Sell
39,785
-1,080
-3% -$135K 0.09% 201
2017
Q1 		$5.53M Sell
40,865
-342
-0.8% -$51.8K 0.08% 201
2016
Q4 		$5.91M Sell
41,207
-444
-1% -$56.7K 0.09% 195
2016
Q3 		$4.92M Sell
41,651
-441
-1% -$53K 0.08% 213
2016
Q2 		$4.46K Sell
42,092
-568
-1% -$63.4K 0.03% 251
2016
Q1 		$4.75M Sell
42,660
-263
-0.6% -$33.3K 0.04% 248
2015
Q4 		$6.72M Buy
42,923
+382
+0.9% +$55.6K 0.05% 245
2015
Q3 		$5.58M Sell
42,541
-694
-2% -$111K 0.04% 257
2015
Q2 		$7.52M Buy
43,235
+1,650
+4% +$297K 0.04% 264
2015
Q1 		$7.17M Sell
41,585
-35
-0.1% -$5.34K 0.04% 293
2014
Q4 		$5.39M Buy
41,620
+3,266
+9% +$421K 0.03% 395
2014
Q3 		$4.93M Buy
38,354
+14,052
+58% +$1.45M 0.02% 492
2014
Q2 		$2.15M Buy
24,302
+12,750
+110% +$1.23M 0.01% 697
2014
Q1 		$1.09M Sell
11,552
-679
-6% -$69.4K ﹤0.01% 825
2013
Q4 		$1.25M Buy
12,231
+7,966
+187% +$718K 0.01% 837
2013
Q3 		$336K Sell
4,265
-1,534
-26% -$112K ﹤0.01% 1113
2013
Q2 		$382K Buy
+5,799
New +$374K ﹤0.01% 1153

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Commerzbank Aktiengesellschaft's UTHR Position: Q4 2019 in Review

Commerzbank Aktiengesellschaft sold out of United Therapeutics (UTHR) in Q4 2019, closing a stake of 40,129 shares — an estimated $3.2M sold.

Commerzbank Aktiengesellschaft first reported a position in UTHR in Q2 2013 and held it in 26 quarters. The position peaked at $7.52M in Q2 2015. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

  • Commerzbank Aktiengesellschaft reported no remaining United Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 40,129 United Therapeutics shares in Q4 2019, an estimated $3.2M.
  • Commerzbank Aktiengesellschaft first reported a position in United Therapeutics in Q2 2013 and held it in 26 quarters.
  • Commerzbank Aktiengesellschaft's United Therapeutics position peaked at $7.52M in Q2 2015.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2019, filed 17 Jan 2020.